Variant report
Variant | nsv980944 |
---|---|
Chromosome Location | chr5:118933077-118953774 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:15)
- CpG islands (count:122)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:15 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr5:118950582-118950884 | H1-hESC | embryonic stem cell: | n/a | chr5:118950732-118950743 |
2 | CEBPB | chr5:118950598-118950884 | K562 | blood: | n/a | chr5:118950732-118950743 |
3 | CEBPB | chr5:118950581-118950898 | Hela-S3 | cervix: | n/a | chr5:118950732-118950743 |
4 | CEBPB | chr5:118950660-118950968 | A549 | lung: | n/a | chr5:118950732-118950743 chr5:118950910-118950923 |
5 | CEBPB | chr5:118950582-118950912 | A549 | lung: | n/a | chr5:118950732-118950743 |
6 | CEBPB | chr5:118950580-118950925 | IMR90 | lung: | n/a | chr5:118950732-118950743 chr5:118950910-118950923 |
7 | CEBPB | chr5:118950558-118950922 | HepG2 | liver: | n/a | chr5:118950732-118950743 |
8 | FOXA2 | chr5:118935375-118935653 | A549 | lung: | n/a | n/a |
9 | MYC | chr5:118935173-118935262 | MCF-7 | breast: | n/a | n/a |
10 | POLR2A | chr5:118943129-118943175 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | POLR2A | chr5:118947774-118947808 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | POLR2A | chr5:118945075-118945101 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | STAT3 | chr5:118943302-118943499 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | TAF7 | chr5:118945184-118945547 | H1-hESC | embryonic stem cell: | n/a | n/a |
15 | TBP | chr5:118945334-118945412 | H1-hESC | embryonic stem cell: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:118943582-118943632 | HCM | heart: | n/a |
2 | chr5:118945798-118945848 | PANC-1 | pancreas: | n/a |
3 | chr5:118945798-118945848 | HPAEpiC | pulmonary alveolar: | n/a |
4 | chr5:118945798-118945848 | HEK293 | kidney: | embryo |
5 | chr5:118943582-118943632 | HCT-116 | colon: | n/a |
6 | chr5:118943582-118943632 | MCF10A-Er-Src | breast: | n/a |
7 | chr5:118943582-118943632 | PFSK-1 | brain: | n/a |
8 | chr5:118943582-118943632 | HRCEpiC | kidney: | n/a |
9 | chr5:118943582-118943632 | PANC-1 | pancreas: | n/a |
10 | chr5:118945798-118945848 | NHBE | bronchial: | n/a |
11 | chr5:118945798-118945848 | HEEpiC | esophagus: | n/a |
12 | chr5:118943582-118943632 | GM19239 | blood: | n/a |
13 | chr5:118945798-118945848 | SKMC | muscle: | n/a |
14 | chr5:118943582-118943632 | H1-hESC | embryonic stem cell: | embryo |
15 | chr5:118945798-118945848 | SK-N-SH | brain: | n/a |
16 | chr5:118945798-118945848 | AG09309 | skin: | n/a |
17 | chr5:118943582-118943632 | HAEpiC | amniotic membrane: | n/a |
18 | chr5:118945798-118945848 | Hepatocyte | liver: | n/a |
19 | chr5:118943582-118943632 | NHDF-neo | bronchial: | n/a |
20 | chr5:118945798-118945848 | GM12891 | blood: | n/a |
21 | chr5:118943582-118943632 | CMK | blood: | n/a |
22 | chr5:118943582-118943632 | LNCaP | prostate: | n/a |
23 | chr5:118943582-118943632 | AG09319 | gingival: | n/a |
24 | chr5:118945798-118945848 | HIPEpiC | eye: | n/a |
25 | chr5:118943582-118943632 | Jurkat | blood: | n/a |
26 | chr5:118945798-118945848 | NB4 | blood: | n/a |
27 | chr5:118943582-118943632 | SK-N-SH_RA | brain: | n/a |
28 | chr5:118945798-118945848 | GM06990 | blood: | n/a |
29 | chr5:118945798-118945848 | NT2-D1 | testis: | n/a |
30 | chr5:118943582-118943632 | HCF | heart: | n/a |
31 | chr5:118943582-118943632 | SK-N-SH | brain: | n/a |
32 | chr5:118945798-118945848 | NHDF-neo | bronchial: | n/a |
33 | chr5:118943582-118943632 | SK-N-MC | brain: | n/a |
34 | chr5:118945798-118945848 | RPTEC | kidney: | n/a |
35 | chr5:118945798-118945848 | HUVEC | blood vessel: | n/a |
36 | chr5:118945798-118945848 | IMR90 | lung: | fetal |
37 | chr5:118945798-118945848 | BE2_C | brain: | n/a |
38 | chr5:118945798-118945848 | SAEC | small airway: | n/a |
39 | chr5:118945798-118945848 | SK-N-MC | brain: | n/a |
40 | chr5:118945798-118945848 | Hela-S3 | cervix: | n/a |
41 | chr5:118943582-118943632 | HRE | kidney: | n/a |
42 | chr5:118945798-118945848 | H1-hESC | embryonic stem cell: | embryo |
43 | chr5:118943582-118943632 | Caco-2 | colon: | n/a |
44 | chr5:118943582-118943632 | HepG2 | liver: | n/a |
45 | chr5:118945798-118945848 | MCF10A-Er-Src | breast: | n/a |
46 | chr5:118945798-118945848 | ProgFib | skin: | n/a |
47 | chr5:118943582-118943632 | A549 | lung: | n/a |
48 | chr5:118945798-118945848 | HRE | kidney: | n/a |
49 | chr5:118945798-118945848 | BJ | skin: | n/a |
50 | chr5:118943582-118943632 | Hela-S3 | cervix: | n/a |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:118804092..118805803-chr5:118943072..118945052,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000239067 | TF binding region |
ENSG00000239067 | CpG island |
ENSG00000239084 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs527430938 | chr5:118941810-118941811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs189439652 | chr5:118941811-118941812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs193042842 | chr5:118941814-118941815 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs557473959 | chr5:118941823-118941824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs577305858 | chr5:118941836-118941837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs540041722 | chr5:118941871-118941872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs116311550 | chr5:118941876-118941877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs111331067 | chr5:118941884-118941885 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs189826767 | chr5:118941893-118941894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs369347741 | chr5:118941940-118941941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs181379187 | chr5:118941944-118941945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs186519634 | chr5:118941947-118941948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs372923063 | chr5:118941958-118941959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs564603853 | chr5:118941974-118941975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs371081489 | chr5:118941980-118941981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs147109434 | chr5:118941981-118941982 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs188631536 | chr5:118942001-118942002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs529195909 | chr5:118942024-118942025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs549047338 | chr5:118942035-118942036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs10519600 | chr5:118942037-118942038 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs138591841 | chr5:118942047-118942048 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs143832449 | chr5:118942055-118942056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs180988247 | chr5:118942061-118942062 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs533607073 | chr5:118942138-118942139 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs185220320 | chr5:118942149-118942150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs191102503 | chr5:118942158-118942159 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs183682601 | chr5:118942201-118942202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs527642810 | chr5:118942202-118942203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs186990881 | chr5:118942213-118942214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs536045787 | chr5:118942228-118942229 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs74361807 | chr5:118942246-118942247 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs539455239 | chr5:118942332-118942333 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs112060750 | chr5:118942345-118942346 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs147246821 | chr5:118942363-118942364 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs578146262 | chr5:118942379-118942380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs550073336 | chr5:118942380-118942381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs560624539 | chr5:118942423-118942424 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs529120916 | chr5:118942451-118942452 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs542783082 | chr5:118942457-118942458 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs562460357 | chr5:118942465-118942466 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs73790902 | chr5:118942495-118942496 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs79172527 | chr5:118942541-118942542 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs570871853 | chr5:118942554-118942555 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs527271553 | chr5:118942568-118942569 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs148733374 | chr5:118942572-118942573 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs10059784 | chr5:118942612-118942613 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs10519601 | chr5:118942621-118942622 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs555963106 | chr5:118942659-118942660 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs532750947 | chr5:118942667-118942668 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs10051870 | chr5:118942685-118942686 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Glaucoma | 21310917 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:118941800-118942000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
2 | chr5:118942000-118945600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
3 | chr5:118942400-118947000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr5:118943000-118943200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
5 | chr5:118943200-118943600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
6 | chr5:118943600-118943800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
7 | chr5:118943600-118946600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr5:118944000-118945000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
9 | chr5:118944600-118946200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
10 | chr5:118944800-118945200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
11 | chr5:118945000-118946400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr5:118945200-118946200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
13 | chr5:118945400-118946400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
14 | chr5:118945600-118946200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
15 | chr5:118945600-118946400 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
16 | chr5:118945800-118946400 | Enhancers | H9 Cell Line | embryonic stem cell |
17 | chr5:118946000-118946400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
18 | chr5:118946200-118947000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
19 | chr5:118946400-118946800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
20 | chr5:118946800-118947200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
21 | chr5:118947000-118947200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |